Diversion Quarterly Report, Q4 2024

Benchmarking your diversion data is crucial to understanding how your drug diversion program is performing. Bluesight’s Diversion Quarterly is a publicly available resource that provides a snapshot of the industry based on aggregated data from ControlCheck customers to help hospitals benchmark their efforts. Those same customers can then benchmark themselves against data from similar-sized hospitals without even leaving the application.